Sideroblastic anemia secondary prevention

Sideroblastic anemia Microchapters
Home
Patient Information
Overview
Historical Perspective
Classification
Pathophysiology
Causes
Differentiating Sideroblastic Anemia from other Diseases
Epidemiology and Demographics
Risk Factors
Screening
Natural History, Complications and Prognosis
Diagnosis
Diagnostic Study of Choice
History and Symptoms
Physical Examination
Laboratory Findings
Electrocardiogram
X Ray
CT
MRI
Ultrasound
Other Imaging Findings
Other Diagnostic Studies
Treatment
Medical Therapy
Surgery
Primary Prevention
Secondary Prevention
Cost-Effectiveness of Therapy
Future or Investigational Therapies
Case Studies
Case #1
Sideroblastic anemia secondary prevention On the Web
Most recent articles
Most cited articles
Review articles
CME Programs
Powerpoint slides
Images
American Roentgen Ray Society Images of Sideroblastic anemia secondary prevention All Images X-rays Echo & Ultrasound CT Images MRI
Ongoing Trials at Clinical Trials.gov
US National Guidelines Clearinghouse
NICE Guidance
FDA on Sideroblastic anemia secondary prevention
CDC on Sideroblastic anemia secondary prevention
Sideroblastic anemia secondary prevention in the news
Blogs on Sideroblastic anemia secondary prevention
Directions to Hospitals Treating Sideroblastic anemia
Risk calculators and risk factors for Sideroblastic anemia secondary prevention

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1] Associate Editor(s)-in-Chief:

Please help WikiDoc by adding content here. It's easy! Click here to learn about editing.

Secondary Prevention

Effective measures for the secondary prevention of sideroblastic anemia include:

• Iron chelators
• Phlebotomy
• Regular liver function tests to assess for liver disease
• Regular CBC in patients with MDS
• Cardiac monitoring
• Monitor iron studies , keep ferriten level < 500 ng/ml
• pyridoxine supplementation, 50-100mg a day.